The largest database of trusted experimental protocols

Ivis lumina xr 3 in vivo imaging system

Manufactured by PerkinElmer
Sourced in United States

The IVIS Lumina XR III is an in vivo imaging system designed for preclinical research. It is capable of capturing bioluminescent and fluorescent signals from small animal models. The system utilizes a highly sensitive charge-coupled device (CCD) camera to detect low-level light emissions from labeled cells or molecules within living subjects.

Automatically generated - may contain errors

3 protocols using ivis lumina xr 3 in vivo imaging system

1

Nanoparticle Characterization and Cellular Uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
The absorption spectrum of a sample was recorded over the wavelength region from 300 nm to 1,200 nm by a UV-3600 spectrophotometer (Shimadzu, Kyoto, Japan). Changes in NP size were measured by dynamic light scattering (DLS) using a Zetasizer Nano-ZS90 (Malvern instruments Ltd., Worcs, UK). The fluorescence images of cellular uptake were obtained using an FV1000 microscope (Olympus, Tokyo, Japan). The fluorescence images of calcein AM/PI staining were obtained with an inverted fluorescence microscope (IX73; Olympus). Transmission electron microscopy (TEM) (JEM-200CX; JEOL Optical Laboratory,Tokyo, Japan) was used to observe the morphology of NPs. A CAD4/PC (Enraf-Nonius, Rotterdam, the Netherlands) was used to assess the X-ray diffraction (XRD) spectra. Inductively coupled plasma optical emission spectrometry (ICP-OES) (OPTIMA 5300 DV; PerkinElmer Inc., Waltham, MA, USA) was utilized to detect the concentration of copper. For the MTT assay, a microplate reader (Infinite® 200 Pro NanoQuant; Tecan, Männedorf, Switzerland) was used to record the absorption values. Fluorescence imaging was obtained with an IVIS Lumina XR III in vivo imaging system (PerkinElmer Inc.). A 1,064 nm laser (Xilong Scientific Co., Ltd., Shantou, China) was utilized in these experiments. A Fotric 225-1 thermal camera (Shanghai, China) was used to quantify the temperature.
+ Open protocol
+ Expand
2

Targeted Cancer Treatment with LnNP@ZIF8

Check if the same lab product or an alternative is used in the 5 most similar protocols
Subcutaneous injection of murine 4T1 cells into Balb/c mice led to the formation of primary tumors. At 21 days after 4T1 cell injection, when the tumor diameter was >7 mm (range, 7–10 mm), ten mice were divided into two groups: treated with LnNP@ZIF8 (LnNP@ZIF8) or treated with LnNP@ZIF8-DOX (LnNP@ZIF8-DOX). The mice were anesthetized using inhaled isoflurane (RWD Life Science, Shenzhen, China). The tumor site was sanitized with a 75% ethanol tincture before treatment. All the procedures were performed aseptically. Then, a 100µL mixture of the LnNPs in PBS (5 mg/mL) was injected subcutaneously into the 4T1 tumors.
Eight of ten SCID tissue-derived orthotopic mice models constructed successfully. Then, a 100 µL mixture of the LnNP@ZIF8-DOX (5 mg/mL) in PBS was injected subcutaneously into the MCF-7 WT and MCF-7 ADR tumors.
NIR-II fluorescent images were recorded at 24 h after probe injection using an in vivo imaging system equipped with an IVIS Lumina XR III in vivo imaging system (PerkinElmer, Waltham, MA, USA).
All mice were sacrificed by cervical dislocation after CO2 euthanasia.
+ Open protocol
+ Expand
3

Establishing PTC Lung Metastasis Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments were operated according to the Guidelines for the Care and Use of Laboratory Animals published by the National Institutes of Health [26 (link)] and approved by the Ethics Committee of Shengjing Hospital of China Medical University. To establish a PTC lung metastasis model, thymic BALB/c nude mice (16–18 g) were used. Stable TPC-1 cells expressing a luciferase and shRNA for circ_102002 (sh-circ_102002) or the control cells (sh-NC) were used. Mice (5 mice/group) were intravenously injected with these cells (1 × 106). At 21 days post-implantation, the tumor-bearing mice were intraperitoneally injected with 100 μl of d-luciferin (10 mg/ml in PBS, Promega, Madison, WI, USA). After 10 min, the fluorescence images of the tumor and lung metastasis in the mice were imaged under anesthesia with 2.5% isofluorane using an IVIS Lumina XR III in vivo imaging system (PerkinElmer, Waltham, CA). Luminescence was expressed as photons/s per region of interest minus background luminescence for a similarly sized region. The lungs were dissected from mice and photographed. Additionally, haematoxylin and eosin (H&E) staining and IHC analysis of HAS2, p-FAK, p-Akt, E-cadherin, and N-cadherin in the tumor tissues were, respectively, conducted. All the antibody information was listed in Supplementary Table S2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!